Guillain-Barré-like syndrome in a child with lead poisoning

Maddalena Toto1, Andrea De Giacomo, Maria Giuseppina Petruzzelli

  • 1Department of Neurologic and Psychiatric Sciences, Child Neuropsychiatry Unit, University of Aldo Moro, Bari, Italy.

Neuropediatrics
|August 23, 2012
PubMed

Insights

Lead poisoning in children, often from environmental exposure, can cause severe neurological damage. A case highlights anemia and neurological symptoms mimicking Guillain-Barré syndrome as potential indicators of lead poisoning in pediatric patients.

Area of Science:

  • Toxicology
  • Pediatrics
  • Neurology

Background:

  • Lead poisoning is a serious health concern, particularly for children, due to potential damage to brain and nerve development.
  • Environmental exposure is the primary cause of lead poisoning, leading to a range of symptoms dependent on exposure levels and duration.

Observation:

  • A 5-year-old girl presented with lead poisoning following accidental ingestion of a metal ring.
  • The child exhibited concurrent anemia, encephalopathy, and peripheral neuropathy.

Findings:

  • The patient's symptoms, including albuminocytological dissociation, mimicked Guillain-Barré syndrome.
  • This presentation underscores the diverse neurological manifestations of lead poisoning in pediatric cases.

Implications:

  • Anemia coupled with central and peripheral nervous system damage in children should raise suspicion for lead poisoning.
  • Early recognition and diagnosis of lead poisoning are crucial to prevent long-term developmental consequences in children.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...